Rheumatoid arthritis. Treatment of early disease
- PMID: 11396100
- DOI: 10.1016/s0889-857x(05)70209-x
Rheumatoid arthritis. Treatment of early disease
Abstract
Treatment of rheumatoid arthritis (RA) is changing with the rapid increase of information on the efficacy of old and new antirheumatic agents. This article provides an opinionated review of the data currently available and makes a case for rapid and aggressive treatment of all patients with RA as early as possible. In the future, corticosteroids will be an important component of such treatment strategies.
Similar articles
-
TNF inhibitors for rheumatoid arthritis - a year in review.Bull NYU Hosp Jt Dis. 2011;69(3):220-4. Bull NYU Hosp Jt Dis. 2011. PMID: 22035432 Review.
-
Treatment of early rheumatoid arthritis: concepts in management.Semin Arthritis Rheum. 2011 Apr;40(5):371-88. doi: 10.1016/j.semarthrit.2010.10.004. Epub 2011 Feb 4. Semin Arthritis Rheum. 2011. PMID: 21295822 Review.
-
Overview of combination second-line or disease-modifying antirheumatic drug therapy in rheumatoid arthritis.Br J Rheumatol. 1995 Nov;34 Suppl 2:96-9. Br J Rheumatol. 1995. PMID: 8535657 Review.
-
Strategies for the management of rheumatoid arthritis.Orthopedics. 2012 Feb;35(2):125-30. doi: 10.3928/01477447-20120123-36. Orthopedics. 2012. PMID: 22300992
-
Therapeutic approaches for early rheumatoid arthritis. How early? How aggressive?Br J Rheumatol. 1995 Nov;34 Suppl 2:87-90. Br J Rheumatol. 1995. PMID: 8535655 Review.
Cited by
-
Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort.Arthritis Res Ther. 2019 Nov 15;21(1):243. doi: 10.1186/s13075-019-2020-x. Arthritis Res Ther. 2019. PMID: 31730497 Free PMC article. Clinical Trial.
-
Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice.Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4556-61. doi: 10.1073/pnas.052523599. Proc Natl Acad Sci U S A. 2002. PMID: 11930008 Free PMC article.
-
Molecular basis of recognition of human osteopontin by 23C3, a potential therapeutic antibody for treatment of rheumatoid arthritis.J Mol Biol. 2008 Oct 17;382(4):835-42. doi: 10.1016/j.jmb.2008.07.075. Epub 2008 Jul 31. J Mol Biol. 2008. PMID: 18694758 Free PMC article.
-
Golimumab for rheumatoid arthritis.Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD008341. doi: 10.1002/14651858.CD008341. Cochrane Database Syst Rev. 2010. PMID: 20091667 Free PMC article.
-
Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project).Ann Rheum Dis. 2004 Sep;63(9):1085-9. doi: 10.1136/ard.2003.016808. Ann Rheum Dis. 2004. PMID: 15308517 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical